Newstral
Article
The Hindu on 2020-12-06 04:35
Pfizer seeks emergency use authorisation for its COVID-19 vaccine in India
Related news
- Pfizer withdraws Emergency Use Authorisation application for its COVID-19 vaccine in IndiaThe Hindu
- U.S. panel recommends authorisation of Pfizer-BioNTech coronavirus vaccineThe Hindu
- Dr Reddy’s eyes March launch of Sputnik V vaccine under Emergency Use AuthorisationThe Hindu
- Pfizer ends COVID-19 vaccine trial with 95% efficacy, to seek emergency-use authorisationThe Hindu
- Ready to roll out COVID-19 vaccine within 10 days of emergency use authorisation: Govt.The Hindu
- DCGI seeking more data for granting emergency use authorisation won’t impact timeline for vaccine roll-out: GovtThe Hindu
- Pfizer seeks emergency use of COVID-19 vaccine in USreviewjournal.com
- Pfizer seeks emergency use of its vaccine in USabqjournal.com
- USFDA authorises Pfizer COVID-19 vaccine for emergency useThe Hindu
- FDA revokes emergency use authorisation for hydroxychloroquineThe Hindu
- BCovid vaccine: Pfizer applies for authorisation in USbbc.co.uk
- 'It's just overwhelming': Moderna to seek emergency authorisation of vaccineSydney Morning Herald
- Dr. Reddy’s initiates Emergency Use Authorisation process for Sputnik VThe Hindu
- Coronavirus live updates | After Pfizer, Serum Institute seeks emergency use nod for Covishield in IndiaThe Hindu
- AstraZeneca, Pfizer Ask India for Emergency-Use Covid-19 Vaccine Authorizationswsj.com
- Pfizer seeks emergency use of its covid-19 vaccine in U.S.nwaonline.com
- After trial success, Pfizer seeks emergency use of its COVID-19 vaccine in UStimesofisrael.com